| READ MAIN PAGE | RSS Feed | RSS Comments | Log in | |
Source: Swissinfo.org On Wednesday, the Japanese heath authorities said they had told importers of Tamiflu to warn doctors not to prescribe it to those aged ten to 19, after two new reports of young people injuring themselves by jumping from buildings after taking the drug. Roche said that it did not understand the rationale behind the Japanese government’s actions. “There’s no proof that Tamiflu causes suicides,” Roche spokeswoman Martina Rupp told swissinfo. “It is allowed all over the world to use Tamiflu from the age of one year onwards.” [more] Comment: Of course they deny it and say there’s no proof. What else would you expect a pharma company to do? Admit to it and open themselves up to trem Leave your own comment |
Pharma Resources
Health Lies Exposed Vaccination News Quackpot Watch Pharma Watch Drug Injury Blog Evidence of Harm Dr. Mercola Vaccine Truth Whistleblowers Law Busting Big Pharma Fraud: Antidepressants
Pharma News
Bullying big pharma pressures Australians Fingering Big Pharma in Philadelphia Free Speech Banned by Big Pharma Pharma Focus Blacklisting honest researchers Pharmaceutical fraud cases Pharmaceutical fraud charges
Pharma Scandals
August's Big Pharma Scandals Reputation of FDA in shambles: Vioxx scandal Behind the Paxil Scandals Vioxx scandal: deeper industry issues NESIRITIDE, a marketing scandal? Hit the drug lords in their pocket book! Big Pharma, quackbusters and 60 Minutes The NIH Scandal and the Future of AIDS Research |
If you have verifiable information or a warning you would like to see added to this web-site then please contact our team at
World Wide Warning and its affiliates have no responsibility for the views, opinions and information communicated here. The contributor(s) and news providers
are fully responsible for this content. In addition, the views and opinions expressed here are not necessarily those of World Wide Warning or its affiliates.
Fair Use Notice: This site may contain copyrighted (C) material the use of which has not always been specifically authorized by the copyright owner.
Such material is made available for educational purposes, to advance understanding of human rights, democracy, scientific, moral, ethical, and social justice issues, etc.
It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in the 'fair use doctrine'. It is distributed without profit.
